Sachem Head Capital Management’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,422,678
Closed -$41.8M 18
2022
Q4
$41.8M Sell
3,422,678
-25,212,822
-88% -$314M 1.63% 12
2022
Q3
$355M Buy
28,635,500
+800,000
+3% +$14M 13.24% 4
2022
Q2
$546M Hold
27,835,500
16.46% 3
2022
Q1
$726M Hold
27,835,500
18.54% 2
2021
Q4
$790M Hold
27,835,500
18.59% 2
2021
Q3
$888M Hold
27,835,500
21.89% 1
2021
Q2
$966M Hold
27,835,500
25.01% 2
2021
Q1
$820M Hold
27,835,500
22.18% 2
2020
Q4
$854M Buy
27,835,500
+24,335,500
+695% +$743M 29.79% 1
2020
Q3
$97.8M Buy
+3,500,000
New +$88.7M 5.93% 8

Other funds holding ELAN

Sachem Head Capital Management's ELAN Position: Q1 2023 in Review

Sachem Head Capital Management sold out of Elanco Animal Health (ELAN) in Q1 2023, closing a stake of 3,422,678 shares — an estimated $41.8M sold.

Sachem Head Capital Management first reported a position in ELAN in Q3 2020 and held it in 10 quarters. The position peaked at $966M in Q2 2021. 389 funds tracked by Wall St. Rank hold ELAN as of Q1 2023.

  • Sachem Head Capital Management reported no remaining Elanco Animal Health position as of Q1 2023 after selling out during the quarter.
  • Sachem Head Capital Management sold 3,422,678 Elanco Animal Health shares in Q1 2023, an estimated $41.8M.
  • Sachem Head Capital Management first reported a position in Elanco Animal Health in Q3 2020 and held it in 10 quarters.
  • Sachem Head Capital Management's Elanco Animal Health position peaked at $966M in Q2 2021.
  • 389 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2023.

Based on Sachem Head Capital Management's 13F filing for Q1 2023, filed 15 May 2023.